↓ Skip to main content

Biologic therapy for autoimmune diseases: an update

Overview of attention for article published in BMC Medicine, April 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)

Mentioned by

blogs
3 blogs
twitter
22 tweeters
patent
3 patents
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
162 Dimensions

Readers on

mendeley
305 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Biologic therapy for autoimmune diseases: an update
Published in
BMC Medicine, April 2013
DOI 10.1186/1741-7015-11-88
Pubmed ID
Authors

Ziv Rosman, Yehuda Shoenfeld, Gisele Zandman-Goddard

Abstract

Biologic therapies for rheumatologic diseases, which are targeted at molecules involved in the mechanisms of the immune system, provide an alternative to the existing treatment methods of disease-modifying anti-rheumatic drugs and other immunosuppressive medications. However, the current drawbacks of biologic therapies, including the inconvenience of intravenous administration, the high costs of these drugs, and the adverse events associated with them, prevent their wide use as first-line medications. This review provides an update of the recent literature on the new biologic therapies available. The review concentrates on nine drugs: tocilizumab, rituximab, ofatumumab, belimumab, epratuzumab, abatacept, golimumab, certolizumab, and sifalimumab, which are used as therapies for rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, systemic sclerosis, or vasculitis.

Twitter Demographics

The data shown below were collected from the profiles of 22 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 305 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 2 <1%
Colombia 1 <1%
Australia 1 <1%
Sweden 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Japan 1 <1%
Unknown 297 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 47 15%
Student > Master 47 15%
Student > Ph. D. Student 43 14%
Student > Bachelor 41 13%
Student > Postgraduate 30 10%
Other 60 20%
Unknown 37 12%
Readers by discipline Count As %
Medicine and Dentistry 107 35%
Agricultural and Biological Sciences 42 14%
Pharmacology, Toxicology and Pharmaceutical Science 26 9%
Biochemistry, Genetics and Molecular Biology 25 8%
Immunology and Microbiology 22 7%
Other 36 12%
Unknown 47 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 48. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2019.
All research outputs
#689,155
of 21,667,499 outputs
Outputs from BMC Medicine
#490
of 3,173 outputs
Outputs of similar age
#4,888
of 175,249 outputs
Outputs of similar age from BMC Medicine
#1
of 1 outputs
Altmetric has tracked 21,667,499 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,173 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 41.4. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,249 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them